Novel imaging could better identify patients who would benefit from implantable cardiac defibrillator

May 10, 2012

New research from the University at Buffalo suggests that cardiologists may have a new way to identify patients who are at the highest risk of sudden cardiac arrest, and the most likely to benefit from receiving an implantable cardiac defibrillator (ICD).

ICDs are used to prevent in patients with advanced heart disease, but many patients' devices are never triggered. New research suggests that imaging the loss of in the heart may identify those patients at greatest risk of developing a life-threatening arrhythmia.

That finding is being reported today as a Late-Breaking Clinical Trial at the Heart Rhythm Society's 33rd Annual Scientific Sessions in Boston.

The UB PAREPET study, or Prediction of Arrhythmic Events with Positron , is the largest PET imaging study ever done on sudden cardiac arrest.

UB researchers used PET imaging to quantify the patients' amount of denervated , where in the heart have died or become damaged due to inadequate blood flow. This was accomplished by imaging the heart's ability to take up a of , the neurotransmitter released from the heart's neurons, using the cyclotron-generated radiopharmaceutical 11C-hydroxyephedrine.

"The principal question we posed with this study was whether the amount of denervated myocardium could predict sudden cardiac arrest," says James A. Fallavollita, MD, UB professor of medicine and lead author on the study. "We found that when at least 38 percent of the heart was denervated, there was a significant increase in the risk of sudden cardiac arrest."

"Ultimately, we wanted to develop an approach that could tackle the problem of identifying a larger portion of the patients with who are at risk of developing sudden cardiac arrest," explains John M. Canty Jr., MD, the Albert and Elizabeth Rekate Professor of Medicine in the UB School of Medicine and Biomedical Sciences and UB's chief of cardiovascular medicine, who was principal investigator of the research. "Since many patients who suffer a cardiac arrest do not have severely depressed heart function, may be able to identify high risk individuals who, in the future, could be considered candidates for an ICD."

Currently, the main criteria for determining who gets an ICD is a measurement of heart function called the ejection fraction, which is the percentage of blood pumped by the heart with each beat. Individuals with an ejection fraction of 35 percent or less are considered candidates for ICDs because they have a significant risk of sudden cardiac arrest.

Funded by the National Institutes of Health, PAREPET involved 204 patients from Western New York with advanced heart disease.

The current research study is a prime example of translational medicine because it came directly out of the laboratory research the UB researchers had performed in animals with chronic ischemic heart disease. These preclinical studies demonstrated that the risk of developing ventricular fibrillation was related to regional myocardial denervation.

"This is as clear an example of translational medicine as there is, with a project being taken from bench-to-bedside by the same investigative team," says Canty. "In our preclinical research, we studied factors that lead to sudden cardiac arrest in animals. This led directly to the human study. This important finding may ultimately impact the care of patients with heart disease."

Explore further: Wearable defibrillator can prevent death in people with arrhythmias

Related Stories

Wearable defibrillator can prevent death in people with arrhythmias

November 13, 2011
A wearable defibrillator can prevent sudden death in people with dangerous heart arrhythmias, according to research presented at the American Heart Association's Scientific Sessions 2011.

Study uncovers novel genetic variation linked to increased risk of sudden cardiac arrest

June 30, 2011
A study by a global consortium of physician-scientists has identified a genetic variation that may predispose people to double the risk of having a sudden cardiac arrest, a disorder that gives little warning and is fatal ...

New heart cells increase by 30 percent after stem cell infusion

November 15, 2011
Healthy, new heart cells have been generated by animals with chronic ischemic heart disease after receiving stem cells derived from cardiac biopsies or "cardiospheres," according to research conducted at the University at ...

Sharp decrease in deaths from sudden cardiac arrest

November 23, 2011
Only a few decades ago, sudden cardiac arrest was a death sentence. Today, a victim of sudden cardiac arrest is saved roughly once every six hours in Sweden, reveals a thesis from the Sahlgrenska Academy at the University ...

Gene variant may predict sudden cardiac death risk for blacks

May 11, 2011
(Medical Xpress) -- Researchers at Duke University Medical Center have pinpointed a common gene variant in blacks that may be associated with the development of life-threatening heart arrhythmias. The finding may help determine ...

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.